NCT06485908
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06485908
Title Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma (MEPENDAX)
Acronym MEPENDAX
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Assistance Publique Hopitaux De Marseille
Indications
Therapies
Age Groups: adult | child
Covered Countries FRA


No variant requirements are available.